|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. FDA Food and Drug Administration FISH fluorescent in situ hybridization FLT3 FMS-like tyrosine kinase 3 GAPPNet Genomic Applications in Practice and Prevention Network HER2 human epidermal growth factor receptor 2 HHS U.S. Department of Health and Human Services HRSA Health Resources and Services Administration IOM Institute of Medicine IVDMIA In Vitro Diagnostic Multivariate Index Assay KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog MEDCAC Medicare Evidence Development and Coverage Advisory Committee NCI National Cancer Institute NIH National Institutes of Health NLA national limitation amount OIVD Office of In Vitro Diagnostic Devices PCR polymerase chain reaction PET positron emission tomography PFS progression-free survival PMA premarket application PSA prostate-specific antigen SACGHS Secretary’s Advisory Committee on Genetics, Health, and Society SACGT Secretary’s Advisory Committee on Genetic Testing UGT1A1 UDP glucuronosyltransferase 1 family, polypeptide A1 USPSTF U.S. Preventive Services Task Force
|
|
|||||||||||||||
